BlackRock’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $227M | Buy |
|
|||||
|
2023
Q3 | $154M | Buy |
|
|||||
|
2023
Q2 | $120M | Buy |
|
|||||
|
2023
Q1 | $120M | Buy |
|
|||||
|
2022
Q4 | $121M | Buy |
|
|||||
|
2022
Q3 | $170M | Buy |
|
|||||
|
2022
Q2 | $162M | Sell |
|
|||||
|
2022
Q1 | $230M | Buy |
|
|||||
|
2021
Q4 | $404M | Buy |
|
|||||
|
2021
Q3 | $470M | Sell |
|
|||||
|
2021
Q2 | $489M | Sell |
|
|||||
|
2021
Q1 | $783M | Buy |
|
|||||
|
2020
Q4 | $940M | Buy |
|
|||||
|
2020
Q3 | $566M | Sell |
|
|||||
|
2020
Q2 | $394M | Buy |
|
|||||
|
2020
Q1 | $229M | Buy |
|
|||||
|
2019
Q4 | $355M | Buy |
|
|||||
|
2019
Q3 | $213M | Buy |
|
|||||
|
2019
Q2 | $261M | Buy |
|
|||||
|
2019
Q1 | $171M | Buy |
|
|||||
|
2018
Q4 | $87.1M | Buy |
|
|||||
|
2018
Q3 | $74.4M | Buy |
|
|||||
|
2018
Q2 | $71.5M | Buy |
|
|||||
|
2018
Q1 | $19.5M | Buy |
|
|||||
|
2017
Q4 | $9.31M | Buy |
|
|||||
|
2017
Q3 | $3.79M | Buy |
|
|||||
|
2017
Q2 | $1.09M | Sell |
|
|||||
|
2017
Q1 | $4.61M | Buy |
|
|||||
|
2016
Q4 | $19K | Sell |
|
|||||
|
2016
Q3 | $27K | Hold |
|
|||||
|
2016
Q2 | $22K | Buy |
|
|||||
|
2016
Q1 | $15K | Buy |
|
|||||
|
2015
Q4 | $11K | Buy |
|
|||||
|
2015
Q3 | $6K | Hold |
|
|||||
|
2015
Q2 | $6K | Sell |
|
|||||
|
2015
Q1 | $7K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $0 | Buy |
|